Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Detection of Bone Marrow Changes: Comparison of MRI and DECT

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gustav Andreisek, University of Zurich
ClinicalTrials.gov Identifier:
NCT01211392
First received: September 28, 2010
Last updated: March 29, 2016
Last verified: March 2016
  Purpose
Prospective study where magnetic resonance imaging is compared to dual-energy computed tomography for the detection of bone marrow changes.

Condition Intervention Phase
Bone Marrow Changes
Other: magnetic resonance imaging
Phase 1

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Enrollment: 40
Study Start Date: October 2010
Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: magnetic resonance imaging
    magnetic resonance imaging is compared to dual-energy computed tomography for the detection of bone marrow changes
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with bone marrow changes
Criteria

Inclusion criteria:

  • Patients with bone marrow changes

Exclusion criteria:

  • Pregnacy
  • Age below 18 ys old
  • Contraindications for MRI
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01211392

Locations
Switzerland
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Gustav Andreisek, MD, University of Zurich
ClinicalTrials.gov Identifier: NCT01211392     History of Changes
Other Study ID Numbers: 005 
Study First Received: September 28, 2010
Last Updated: March 29, 2016
Health Authority: Switzerland: Swissmedic

ClinicalTrials.gov processed this record on September 28, 2016